Snowball logo
logo
DNTH

Dianthus Therapeutics Inc.

DNTH β€’ NASDAQ
$95.35+$3.78Β  (4.13%)

Frequently asked questions

What sector does Dianthus Therapeutics Inc. (DNTH) operate in?

Dianthus Therapeutics Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Dianthus Therapeutics Inc. (DNTH) current stock price?

As of the latest data, Dianthus Therapeutics Inc. stock price is $95.35, with a previous close of $91.57. Dianthus Therapeutics Inc. gained $3.78 in the last trading session, representing a 4.13% increase.

What is Dianthus Therapeutics Inc. (DNTH) current market capitalization?

Dianthus Therapeutics Inc. market cap is approximately 5.21 billion.

What is Dianthus Therapeutics Inc. (DNTH) Earnings Per Share (EPS)?

The trailing EPS is -$4.23, and the forward EPS is -$4.65.

What is Dianthus Therapeutics Inc. (DNTH) EBITDA?

Dianthus Therapeutics Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -40.76 million.

Does Dianthus Therapeutics Inc. (DNTH) pay dividends?

No. Dianthus Therapeutics Inc. does not pay a dividend.

How did Dianthus Therapeutics Inc. (DNTH) perform in its most recent earnings report?

In the last report (March 31, 2026), Dianthus Therapeutics Inc. posted an EPS surprise of 22.73% and a revenue surprise of 29.08%.

When is Dianthus Therapeutics Inc. (DNTH) next earnings report?

Dianthus Therapeutics Inc. is expected to release its next earnings report on June 30, 2026.

What is Dianthus Therapeutics Inc. (DNTH) beta (volatility) score?

Dianthus Therapeutics Inc. has a beta of 0.066, indicating lower volatility than the overall market.